All terms in GO

Label Id Description
ganglioside GT1b binding GO_1905576 [Binding to ganglioside GT1b.]
ganglioside GP1c binding GO_1905577 [Binding to ganglioside GP1c.]
mineralocorticoid secretion GO_0035931 [The regulated release of any mineralocorticoid into the circulatory system. Mineralocorticoids are a class of steroid hormones that regulate water and electrolyte metabolism.]
corticosteroid hormone secretion GO_0035930 [The regulated release of any corticosteroid hormone into the circulatory system.]
aldosterone secretion GO_0035932 [The regulated release of aldosterone into the circulatory system. Aldosterone is a pregnane-based steroid hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.]
androgen secretion GO_0035935 [The regulated release of an androgen into the circulatory system. Androgens are steroid hormones that stimulate or control the development and maintenance of masculine characteristics in vertebrates.]
positive regulation of low-density lipoprotein particle clearance GO_1905581 [Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.]
testosterone secretion GO_0035936 [The regulated release of testosterone into the circulatory system. Testosterone is an androgen having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.]
response to mannose GO_1905582 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mannose stimulus.]
glucocorticoid secretion GO_0035933 [The regulated release of any glucocorticoid hormone into the circulatory system. Glucocorticoids are a class of steroid hormones that regulate a variety of physiological processes, in particular control of the concentration of glucose in blood.]
corticosterone secretion GO_0035934 [The regulated release of corticosterone into the circulatory system. Corticosterone is a 21-carbon steroid hormone of the corticosteroid type produced in the cortex of the adrenal glands.]
positive regulation of ERBB3 signaling pathway GO_1905580 [Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.]
microsatellite binding GO_0035939 [Binding to a microsatellite, a repeat_region in DNA containing repeat units (2 to 4 base pairs) that is repeated multiple times in tandem.]
satellite DNA binding GO_0003696 [Binding to satellite DNA, the many tandem repeats (identical or related) of a short basic repeating unit; many have a base composition or other property different from the genome average that allows them to be separated from the bulk (main band) genomic DNA.]
negative regulation of outer hair cell apoptotic process GO_1905586 [Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.]
estrogen secretion GO_0035937 [The regulated release of estrogen into the circulatory system. Estrogen is a steroid hormone that stimulates or controls the development and maintenance of female sex characteristics in mammals.]
cellular response to mannose GO_1905583 [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mannose stimulus.]
estradiol secretion GO_0035938 [The regulated release of estradiol into the circulatory system.]
outer hair cell apoptotic process GO_1905584 [Any apoptotic process in an outer hair cell.]
obsolete regulation of ergosterol biosynthetic process by regulation of transcription from RNA polymerase II promoter GO_0035960 [OBSOLETE. Any process that modulates the frequency, rate or extent of ergosterol biosynthetic process by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.]